Stockreport

Why The Narrative Around Esperion Therapeutics Is Shifting After Analyst Upgrades And Trial Results [Yahoo! Finance]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Esperion Therapeutics has seen its fair value estimate nudged higher to about $6.50 per share from roughly $6.15, even as the discount rate holds steady near 6.96% and r [Read more]